The head of the clinical development program at Galapagos discussed the company's data presented at EHA's 2025 Congress.
Omotayo Fasan, MRCP, DTM&H, MBBS
Advertisement
Omotayo Fasan, MRCP, DTM&H, MBBS, the head of the clinical development program at Galapagos
Articles by Omotayo Fasan, MRCP, DTM&H, MBBS
Advertisement
Latest Updated Articles
Omotayo Fasan, MBBS, MRCP, DTM&H, on Evaluating CAR T-Cell Therapy GLPG5101 in R/R NHLPublished: June 15th 2025 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Quarter Century Update: Thoughts on Reducing Costs of Goods
4
Quarter Century Update: Future Predictions for the Field
5
